Key Facts about Progynova Injection

Progynova injection has been reported to cause an increased risk of breast, uterine, and endometrial cancer (cancer in the lining of the uterus). For this reason it is essential to have regular mammograms and checkups. Tell your doctor if you notice any unusual vaginal bleeding. If this medication is taken along with progestins, it may lower the risk of uterus cancer. If your uterus has not been removed, your doctor may prescribe a progestin for you to take while you are using this injection.      

This drug may not be right for you if you have any of the following conditions: a history of stroke or blood clot, circulation problems. This medication can lead to birth defects in a fetus. Avoid using it if you are pregnant. Employ an effective form of birth control, and tell your doctor if you become pregnant during treatment.      

Use of progynova injection may interfere in certain laboratory tests. That’s why it should be started at a lowest dose approved for the indication. Besides, the response should be observed along with serum hormone levels (e.g., estradiol, FSH).   

Some diseases may occur if this therapy is continued for long. These are heart attack, or stroke and breast cancer. Discuss with your doctor about your individual risks before using estradiol for long. You may need to check your progress on a regular basis (every 3 to 6 months) to settle on whether you should continue this treatment.  

Make physical exams on regular basis and self-examine your breasts for lumps on a monthly basis while using progynova.   

This therapy, with or without progestin, should not be administered to treat heart disease. Studies show that this drug increase rate of stroke, heart attack, and dangerous blood clots among women taking estrogen or estrogen combinations for 5 years. Blood clots can give rise to stroke, heart attack, phlebitis, a loss of blood supply to the lungs, a blockage in the blood vessels serving the eye, and other serious disorders. As a result of these risks, this therapy should be given at the lowest effective dose for the shortest possible time. Your doctor will determine the dosage that is best for you.  

It is essential to avoid this product in patients having unexplained vaginal bleeding, phlebitis, blood clots in the lung, or any other clotting disorder, liver disease or liver problems, known or suspected breast cancer, any type of tumor stimulated by estrogen, active or recent (within the last year) heart disease, heart attack, or stroke, an allergy to any component of the drug.  

Progynova may lead to some degree of fluid retention. Hence patients with conditions that might be influenced by this factor, such as asthma, epilepsy, migraine, and cardiac or renal dysfunction, call for careful inspection when estrogens are prescribed.

Long term and repeated use of natural and synthetic estrogens in certain animal species increases the occurrence of carcinomas of the cervix, vagina, testis, breast, uterus, and liver. Progynova should not be given to patients who have allergic to this drug or any of its ingredients.